Introduction

Melioidosis is a tropical infection caused by the Gram-negative soil saprophyte Burkholderia pseudomallei. Disease may occur after bacterial inhalation, ingestion or cutaneous inoculation. Clinical manifestations are diverse but lung involvement is very common.1 Mortality from melioidosis in northeast Thailand is 40%. Exposure to B. pseudomallei in northeast Thais appears widespread as seropositivity occurs in 70% of children by age 4, but the annual incidence is about 21 cases per 100 000.2, 3 Diabetes, present in about 50% of cases, is the main risk factor, but whether there are other explanations for the low incidence of disease given the high exposure to the bacterium remains unclear.1

A genetic influence on susceptibility to infection has been clearly established.4 Two small studies implicate genetic variation in susceptibility to melioidosis.5, 6 Previous human genetic studies of Gram-negative infections have predominantly examined sepsis of heterogeneous microbial etiologies rather than large populations with infections caused by a single bacterium. Genetic studies of pneumonia have similarly been limited by small sample sizes for any single pathogen. Study of host genetics in a large cohort of melioidosis subjects, including a sizable number of pneumonic cases, is therefore pertinent.

Toll-like receptors (TLRs) are pathogen-recognition receptors that initiate an inflammatory response upon ligation by conserved motifs on invading pathogens.7 TLR pathway genetic variation is associated with susceptibility to various infections or altered outcome from infection in numerous studies.8 Experimental data indicate that TLRs 2, 4 and 5 modulate the host response to B. pseudomallei, likely activated by bacterial lipopeptides, lipopolysaccharide (LPS) and flagellin, respectively.9, 10 (West TE, unpublished data). TLRs 1 and 6 form heterodimers with TLR2.7 TIRAP (also known as MAL) is an adaptor molecule that is recruited upon ligation of TLRs 2 or 4.7 We performed a case–control candidate gene study at a large referral hospital in northeast Thailand to test the hypothesis that variation in TLR pathway genes is associated with the development of melioidosis in a widely exposed population. The study was undertaken in two parts: First, a primary list of well-characterized single nucleotide polymorphisms (SNPs) in TLR pathway genes was defined and analyzed. Second, significant SNP associations prompted the analysis of additional variants from the pertinent gene regions.

Results

Four hundred and ninety B. pseudomallei culture-positive hospitalized cases, 950 non-hospitalized controls presenting to outpatient clinic or the blood donation center, and 458 B. pseudomallei culture-negative hospitalized controls with clinical signs of infection were identified at Sappasithiprasong Hospital, Ubon Ratchathani, Thailand. Characteristics of cases and controls are shown in Table 1.

Table 1 Characteristics of cases and controls

We first tested the association between eight well-characterized TLR pathway gene SNPs and susceptibility to melioidosis in cases compared with non-hospitalized controls. These SNPs are either well defined functionally or have been associated with susceptibility or outcome to infection in multiple studies.8, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26 Only TLR41196C>T was significantly associated with melioidosis in a general genetic model comparing genotype frequencies (P=0.05) (Table 2). In a dominant model adjusted for age, sex and diabetes status, the variant significantly conferred over a threefold protective effect (odds ratio (OR) 0.29, 95% confidence interval (CI): 0.09–0.99, P=0.05). Unlike in Caucasian populations, TLR41196C>T and TLR4896A>G were not in very strong linkage disequilibrium (LD) (r2=0.69) and the minor allele frequency for each variant was 1%. In the subgroups of cases with bacteremia or pulmonary involvement, no variants were significantly associated with disease (Supplementary Table 1).

Table 2 Associations of TLR pathway genetic variants with melioidosis

We then tested the association of the primary SNPs with melioidosis compared with hospitalized controls. As most melioidosis cases were identified by screening hospitalized patients, this control group may better represent the source population. None of the SNPs was significantly associated with disease in unadjusted models, but in recessive models adjusted for age, sex and diabetes, associations of TLR1742A>G and TLR1−7202A>G with disease were significant (Table 2). In adjusted analyses, both of these variants were significantly associated with bacteremia, and TLR1742A>G was associated with pulmonary involvement compared with hospitalized controls (Table 3). TLR1742A>G and TLR1−7202A>G were in high LD (r2=0.84) and had similar allele frequencies to TLR1742A>G in a Vietnamese population.26 In these adjusted models, the effect of diabetes on case–control status was very strong (OR 3–4) (Tables 2 and 3), prompting us to evaluate whether a diabetes-specific effect of TLR1 variants existed. Further analyses were performed to test the association of each TLR1 SNP in melioidosis cases compared with hospitalized controls, stratifying by diabetes status. No significant associations were observed (Supplementary Table 2).

Table 3 Associations of TLR1 variants with bacteremic or pulmonary melioidosis compared to hospitalized controls

To test for population stratification between cases and controls, 25 independent SNPs from across the genome were genotyped.27 We conducted allelic analyses calculating the χ2 statistic for 24 of these SNPs (rs169479 had no variation) and determined the mean χ2 (Supplementary Table 3). For cases compared with non-hospitalized controls and to hospitalized controls, respectively, the mean χ2 was 1.18 and 0.96. The proximity of these numbers to 1 suggested that minimal population stratification exists.28

Asian populations are underrepresented in studies of TLR pathway genetic variation and disease. Given the initial findings of associations of TLR4 and TLR1 variants with melioidosis, in the second phase of the study additional coding SNPs and haplotype-tagging SNPs in the TLR4 and TLR6-1-10 regions in Asian populations (selected as described in Materials and methods) were analyzed. Eight TLR4 region SNPs and 18 TLR6-1-10 region SNPs (Supplementary Table 4) were tested for associations with melioidosis compared with each of the two control groups.

Two of the eight TLR4 region SNPs showed an association with melioidosis (Table 4). rs10818066 was significantly associated with melioidosis in an unadjusted model when tested versus non-hospitalized controls but not when compared with hospitalized controls. In an adjusted model, the effect of the variant was significantly protective for both sets of control groups. When compared with each control group, rs960312 was significantly associated with disease in unadjusted models and the variant significantly increased susceptibility in adjusted models. Applying a conservative Bonferroni correction for multiple comparisons, several associations remained significant (Table 4). In subsequent adjusted analyses, rs10818066 was associated with bacteremic or pulmonary melioidosis when compared with either control group (Supplementary Table 5). rs960312 was associated with bacteremic and pulmonary melioidosis in unadjusted analyses when compared with hospitalized controls. In adjusted models, the variant was associated with pulmonary melioidosis compared with either control group.

Table 4 Associations of TLR4 region variants with melioidosis

None of the three significant TLR4 region variants, TLR41196C>T, rs10818066 or rs960312, was in high LD with each other in the entire population (Figure 1). To examine the combined effects of these polymorphisms on melioidosis susceptibility, haplotypes with frequencies >1% were constructed (Table 5). The association with disease was examined compared with each of the two control groups using additive, dominant and recessive models. The effects observed were comparable to those attributable to rs10818066 or rs960312 in isolation.

Figure 1
figure 1

LD of TLR4 region SNPs in Thais. Genetic map indicates location of SNPs relative to TLR4 on chromosome 9. Numbers within LD map denote r2 values. Figure generated by Haploview and modified.

Table 5 TLR4 region haplotype

The associations with disease of TLR6-1-10 region SNPs were examined, stratifying by diabetes status based on our initial analysis. There were few significant associations among subjects without diabetes (Supplementary Table 6) or in diabetics when comparing melioidosis cases to non-hospitalized controls (Table 6). Comparing diabetic melioidosis cases with hospitalized diabetic controls, 3 of 16 SNPs in Hardy–Weinberg equilibrium were strongly associated with disease: rs2087465, rs3924112 and rs5743794 (Table 6). In adjusted models, these associations persisted. The association of rs2087465, a non-coding SNP in the TLR6 region, was significant even after applying a Bonferroni correction. In an adjusted analysis, the magnitude of protection conferred by this variant was particularly large (OR 0.13, 95% CI: 0.03–0.48, P=0.002).

Table 6 Associations of TLR6-1-10 region variants with melioidosis in diabetics

None of these three SNPs was in strong LD with each other (r2 for each pair <0.7). Haplotypes were constructed with all three SNPs and the association with disease was tested in hospitalized diabetics. The additive model haplotype comprised of the rare allele at all three loci occurring in 21% of controls, resulted in the largest significant effect (OR 0.49, 95% CI: 0.33–0.75, P=0.001).

Discussion

This study of nearly 1900 Thais at risk for melioidosis is the largest study of human genetic variants and susceptibility to melioidosis, and the first to examine genetic variations in pattern recognition receptor pathways. This study is also notable as one of the few large investigations of host genetic factors underlying Gram-negative infection. Based on an abundant literature implicating TLR pathway variants in susceptibility to or outcome from infection, this pathway was targeted in our analysis of melioidosis patients. Our main findings are that TLR4 region gene variants are associated with melioidosis, and in hospitalized diabetics, TLR6-1-10 gene variants are associated with differential susceptibility to melioidosis than to other illnesses.

As the primary host receptor for LPS, TLR4 is the canonical TLR for Gram-negative pathogens. B. pseudomallei is a Gram-negative pathogen that induces an inflammatory response that is TLR4-dependent, and B. pseudomallei lipopolysaccharide is a TLR4 agonist.9 Therefore, there is compelling in vitro evidence for the importance of TLR4 in melioidosis. The role of TLR4 in mouse models of respiratory Burkholderia infection is less apparent,10, 29 but in human cases of melioidosis, TLR4, MD2 and CD14 are all expressed at higher levels than in controls.10

Polymorphisms in TLR4 have been extensively studied.8 The two best-known SNPs are at positions 896 and 1196. They are typically in high LD in Caucasian populations, where they occur more frequently than in Asian populations. Several studies suggest that these SNPs are associated with susceptibility to sepsis18, 30 but not to meningococcal or pneumococcal infection.31, 32, 33, 34, 35 The SNPs are linked with resistance to legionellosis and to recurrent urinary tract infections.23, 36 Thus their role may be population- and infection-specific. In this study, a substantial protective effect of the extremely rare TLR41196C>T allele was observed when compared with non-hospitalized controls but not in comparison with hospitalized controls. A likely explanation is that many hospitalized control subjects had other infections or undiagnosed melioidosis that are similarly associated with a lower frequency of the minor allele. A role for TLR4 in human melioidosis is greatly supported by our additional findings of an association with disease attributable to two other TLR4 region variants, regardless of control group chosen for comparison. The rs10818066 variant also conferred protection against melioidosis but the rs960312 variant was associated with susceptibility to disease. A comparable pattern of effect for TLR41196C>T and rs960312 was observed in a study of genetic associations with liver fibrosis in Caucasians.37 That rs10818066 and rs960312 are located in intergenic regions and are not in LD with TLR41196C>T suggests that these SNPs are in LD with other unidentified causative variants. We hypothesize that altered TLR4-dependent host responses to B. pseudomallei lipopolysaccharide in carriers of these causative variants modulate host susceptibility to successful infection by the invading pathogen. Resequencing of the TLR4 region in this little-studied population and careful assessments of functional effects of variants will be required to further test this hypothesis. In aggregate, these data provide the strongest evidence to date that TLR4 is an important element of host defense in human melioidosis.

Our data also suggest that in diabetics, TLR6-1-10 region variants regulate differential susceptibility to melioidosis compared with other illnesses. While the function of TLR10 in humans remains unclear, TLRs 1 and 6 form heterodimers with TLR2 to permit signaling upon ligation by bacterial cell wall components. Both TLRs 1 and 6 augment TLR2-dependent signaling upon stimulation with heat-killed B. pseudomallei.9 TLR2 deficiency may heighten the cytokine response to B. pseudomallei in macrophages and confers protection in murine studies of respiratory infection.9, 10 In Caucasians, the high LD TLR1 SNPs TLR1742A>G, TLR1−7202A>G and TLR11804G>T are linked with immunomodulatory effects and sepsis outcomes.13, 26 Diabetes is a defined risk factor for melioidosis, and studies have demonstrated B. pseudomallei-specific defects in neutrophil functions such as phagocytosis, reduced chemotaxis and resistance to apoptosis.38 Altered TLR signaling occurs in diabetics39 but this has not been extensively studied during infection. Here, we demonstrate that in diabetics, TLR6-1-10 region variants are associated with differential susceptibility to melioidosis than to other illnesses. We did not find that these variants are associated with susceptibility to melioidosis compared with otherwise healthy subjects. Homozygosity of the rs2087465 minor allele confers a nearly eight-fold protective effect against melioidosis in hospitalized diabetics. As the frequency of this allele is comparable in diabetics with melioidosis and in otherwise healthy diabetics, however, an alternative explanation is that this allele markedly heightens susceptibility to non-melioidosis illness in diabetics. Review of available diagnoses in the hospitalized diabetic controls revealed a large spectrum of infectious illnesses, including pneumonia, sepsis, tuberculosis, leptospirosis, as well as non-infectious processes. Thus, our data provide evidence that the relative importance of different innate immune receptors may vary depending on underlying diseases as well as on specific infection. Additional study of genetic variation in TLR6-1-10 in both non-diabetics and diabetics in this population is indicated.

There are several limitations to this study. It is possible that our cases were not selected from the same population as controls—a rationale for selecting two control groups—but we did not observe significant population stratification. The exposure of the cases and controls may have differed but studies have shown widespread seropositivity to B. pseudomallei in the local population.2 While replicating genetic associations in another cohort is desirable, there are few locations where a comparable study of melioidosis host genetics could be undertaken. Thus, as large a study as possible with multiple control groups was designed. The results underscore the importance of generating additional genetic data in Thai and other southeast Asian populations.

In conclusion, TLR4 genetic variants are associated with melioidosis in a Thai population. In diabetic populations, TLR6-1-10 variants are associated with differential susceptibility to melioidosis compared with other illnesses. Further investigations of causative genetic variants and mechanisms of susceptibility in this population are required.

Materials and methods

Clinical study design

Cases (n=490) were identified among inpatients at Sappasithiprasong Hospital, Ubon Ratchathani, northeast Thailand from 1999 to 2005. A study team screening patients with clinical signs of infection cultured blood, urine and other relevant samples (for example, abscess aspirates) for B. pseudomallei.40 Case status was defined by a positive culture for B. pseudomallei from a sample collected by the study team or independently by hospital clinicians. Two separate groups of control subjects were defined. The first group totaled 950 non-hospitalized subjects. As the majority of melioidosis cases have underlying diabetes, this control group combined 475 healthy individuals who presented to the blood donation center and 475 otherwise healthy diabetics recruited from the outpatient diabetes clinic at the hospital between 2007 and 2008. A second control group was comprised of 458 hospitalized subjects with clinical signs of infection who were screened for melioidosis by the study team but were culture negative for B. pseudomallei. An exclusion criterion for all control subjects was a previous history of melioidosis. The University of Washington Human Subjects Division Institutional Review Board, Ethical Review Committee for Research in Human Subjects, Ministry of Public Health, Thailand, and the Ethics Committee of the Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand approved this study.

Genomic methods

From the literature, SNPs in TLR pathway genes (TLR1, TLR2, TLR4, TLR5 and TIRAP) with well-defined functional effects or associated with altered susceptibility to or outcome from infection were identified. Owing to little published data on genetic variation in Thais, additional SNP identification and selection was performed using the Genome Variation Server (http://gvs.gs.washington.edu/GVS/). Coding SNPs in candidate genes were selected. Within the region encompassed by 50 000 bases upstream and downstream of each candidate gene, SNPs with a minor allele frequency 2% in populations identified as Japanese, Chinese and Asian were binned into groups with r20.8 to identify haplotype-tagging SNPs. DNA was extracted from whole blood using Nucleon BACC3 kits (GE Healthcare, Buckinghamshire, UK). Genotyping was performed using an allele-specific primer extension method (Sequenom Inc., San Diego, CA, USA) with reads by a MALDI-TOF mass spectrometer.41

Statistical methods

The study analysis was undertaken in two phases. First, a primary list of SNPs was defined: TIRAP539C>T, TIRAP558C>T, TLR11804G>T, TLR2597C>T, TLR22258G>A, TLR4896A>G, TLR41196C>T and TLR51174C>T. Each SNP has either been associated with susceptibility to infection or outcome from infection in a previous study or has been shown to regulate cell function.11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 In Caucasian populations, TLR11804G>T is in high LD with two other TLR1 SNPs: TLR1742A>G, another non-synonymous coding SNP, and TLR1−7202A>G, a tagging SNP,13, 26 although TLR1742A>G and TLR11804G>T are not in LD in a Vietnamese population.26 TLR11804G>T could not be readily accommodated in our plex design, so both TLR1742A>G and TLR1−7202A>G were genotyped instead. The minor allele frequency for TLR22258G>A was 0% in our population. Therefore, the eight final SNPs analyzed were: TIRAP539C>T (rs8177374), TIRAP558C>T (rs7932766), TLR1742A>G (rs4833095), TLR1−7202A>G (rs5743551), TLR2597C>T (rs3804099), TLR4896A>G (rs4986790), TLR41196C>T (rs4986791) and TLR51174C>T (rs5744168). The frequency of these SNPs was compared in cases versus controls. Based on the initial results suggesting hits for TLR4 and TLR1 SNPs, additional variants in these genes were examined in the second phase of the analysis. TLR1 is part of a locus comprising TLR6, TLR1 and TLR10, so SNPs from this entire locus were selected. The secondary SNPs are listed in Supplementary Table 4.

SNPs were first examined for deviation from Hardy–Weinberg equilibrium in the control populations studied using the Fisher's exact test. The association between genotype and disease was analyzed using a χ2 test except when cell values in the table were <10, in which case the Fisher's exact test was chosen. Logistic regression was performed with an appropriate genetic model (dominant or recessive), adjusting for age, sex and (where suitable) diabetes status. In the initial study phase, two additional analyses were performed defining cases as the subgroup of patients with bacteremia or as those with lung involvement or pleural effusions. No adjustment was made for multiple comparisons in this initial phase because of previously demonstrated associations or functional effect of each of the eight primary SNPs. Twenty-five unrelated SNPs from across the genome were genotyped and the mean χ2 statistic for the comparison of allele frequencies between cases and non-hospitalized controls was examined as a measure of population stratification.27, 28 In the subsequent study phase, a conservative Bonferroni correction was applied to multiple comparisons to maintain the desired family-wise type I error rate. Unadjusted haplotypes containing relevant variants were constructed using additive, dominant, or recessive models. All analyses were performed with Stata version 11.1 (College Station, TX, USA) incorporating pwld, genhw and haplologit functions. P-values 0.05 were considered significant. LD mapping was performed with Haploview v4.2.42